Navigation Links
New approach to protecting prion protein from altering shape
Date:7/18/2013

A team of researchers from Case Western Reserve University School of Medicine have identified a mechanism that can prevent the normal prion protein from changing its molecular shape into the abnormal form responsible for neurodegenerative diseases. This finding, published in the July 18 issue of Cell Reports, offers new hope in the battle against a foe that until now has always proved fatal.

Prion diseases include Creuzfeldt-Jakob disease and fatal familial insomnia. Unlike other transmissible diseases, the infectious agent is not a virus or bacteria, but an abnormally shaped prion protein. Scientists believe it self-replicates by binding to normal prion proteins and forcing them to change shape to become an abnormal, and thus diseased, protein.

"Once heretical, the notion that proteins alone can act as self-propagating infectious agent is now becoming accepted as a new paradigm in biology and medicine. However, the mechanism by which prion protein changes its shape remains largely unknown and highly controversial, hindering efforts to develop drugs for prion diseases," said Witold Surewicz, PhD, professor of physiology and biophysics and senior author of the study. "A heated debate continues as to which part of the prion protein undergoes the change and what is the three-dimensional structure of the infectious form of the protein."

The researchers generated a variant of prion protein designed to stabilize the normal shape of one specific part of the protein. They accomplished this goal by replacing just one out of more than 200 amino acid residues, the building blocks of the protein. In a series of experiments, the researchers found that the modified prion protein was highly resistant to changing its shape. In other words, this approach may be successful in blocking the coercive action of the abnormal prion protein.

The team then created transgenic mice that produced this "superstable" human prion protein and infected them with Creutzfeldt-Jakob disease prions. The mice did eventually develop symptoms, but the signs did not emerge for more than a year in fact, it took about 400 days. In contrast, mice without the modified prion protein showed symptoms within 260 days.

"Our discovery that a tailor-made mutation in one specific region of prion protein can prevent it from changing shape to a disease-associated conformation helps resolve the ongoing major controversy in the field regarding the mechanism by which infectious prions self-replicate," said Qingzhong Kong, PhD, associate professor of pathology and first author on the paper.

With no effective treatments currently available for these fatal diseases, this finding has also important implications for the development of new drugs. It suggests a novel pharmacologic strategy in which scientists can either identify or design a molecule that binds to prion protein and stabilizes its normal shape, thereby preventing propagation of the disease.


'/>"/>

Contact: Jessica Studeny
jessica.studeny@case.edu
216-368-4692
Case Western Reserve University
Source:Eurekalert

Related biology news :

1. New data support community-wide approach to addressing child obesity
2. A Future-Proof Approach to Intelligent Buildings
3. New chemical approach to treat Alzheimers
4. Agencies should use common approach to evaluate risks pesticides pose to endangered species
5. Novel therapeutic approaches to cure chronic HBV infection
6. BUSM researchers identify novel approach to study COPD and treatment efficacy
7. Vitamin P as a potential approach for the treatment of damaged motor neurons
8. Einstein study reveals new approach for stopping herpes infections
9. Novel treatment approach for bladder pain using a herpes simplex virus vector reported
10. New approaches for controlling pesticide exposure in children
11. New approach alters malaria maps
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)... PORTLAND, Oregon and PUNE, India , January 12, 2017 ... Technology Market: Opportunities and Forecasts, 2015 - 2022," projects that the global biometric technology ... CAGR of 19.4% from 2016 to 2022. Continue Reading ... ... ...
(Date:1/6/2017)... LA JOLLA, Calif. , Jan. 6, 2017 ... Phase 1 safety studies in healthy volunteers of ... CM4620, intended to treat acute pancreatitis. ... pancreas, is typically a mild disorder, but can ... to organ failure and sepsis, where extended hospital ...
(Date:1/4/2017)... 4, 2017  For the thousands of attendees at this year,s International ... connected health and biometric measurement devices and services, will be featuring its ... display in A&D Medical,s special CES Exhibit Suite , the new ... of the company,s WellnessConnected product platform.  ... ...
Breaking Biology News(10 mins):
(Date:1/24/2017)... 24, 2017  Bruker today announced that ... leader in the development, manufacture, and sale ... Hysitron,s innovative nanomechanical testing instruments to Bruker,s ... surface profilometers, and tribology and mechanical testing ... nanomaterials research markets. Hysitron,s 2016 revenues were ...
(Date:1/24/2017)... ... January 24, 2017 , ... ... and increased serum leptin levels had a positive association with increased prostate growth ... published in the International Neurourology Journal involved 571 Korean men who underwent ...
(Date:1/24/2017)... , Jan. 24, 2017 /PRNewswire/ - ProMetic Life Sciences Inc. ... today that its orally active lead drug candidate, PBI-4050, ... by the UK Medicines and Healthcare Products Regulatory Agency ... A PIM designation is an early indication ... the Early Access to Medicines Scheme ("EAMS"), intended for ...
(Date:1/24/2017)... 23, 2017  Recognizing the need to grow ... and solutions, the University of Miami announced Monday ... Science and Engineering to achieve those milestones by ... help solve some of the world,s most pressing ... Julio Frenk unveiled the network of intertwined ...
Breaking Biology Technology: